|
|
|
|
- BIBCOL is expected to formulate 100 million doses of OPV from bulk and supply to National Immunization Prgoram during the year 2005-2006.
- Acquiring VSQ-Pre Qualification certification of WHO, a mandtory requirment for supply of OPV to UN agencies.
- Contribution for total eliminiation of polio from the country through continuous support to National Immunization Program.
- Expansion of Product Portfolio such as production of DPT, Measles, IPV and Heapatitis B Vaccines.
- Manufacture of various neutraceuticals and biologicals for treatment of health deficiencies and disorders.
| |
| |
| | |
